908 Devices (MASS) Aperçu de l'action
908 Devices Inc. fournit des appareils portatifs de spectrométrie de masse et d'infrarouge à transformée de Fourier (FTIR) destinés à des applications vitales en matière de santé et de sécurité. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 1/6 |
| Croissance future | 1/6 |
| Performances passées | 0/6 |
| Santé financière | 6/6 |
| Dividendes | 0/6 |
MASS Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
908 Devices Inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$9.69 |
| Plus haut sur 52 semaines | US$11.25 |
| Plus bas sur 52 semaines | US$5.03 |
| Bêta | 0.68 |
| Variation sur 1 mois | 10.11% |
| Variation sur 3 mois | 17.88% |
| Variation sur 1 an | 70.00% |
| Variation sur 3 ans | 51.17% |
| Variation sur 5 ans | -73.63% |
| Évolution depuis l'introduction en bourse | -80.22% |
Nouvelles et mises à jour récentes
MASS: Higher 2026 Revenue Outlook Will Support A Stronger Share Price
Analysts have raised the 908 Devices fair value estimate from $11 to $13, citing updated assumptions on the discount rate, revenue growth, profit margin, and future P/E that shift their overall price target framework. What’s in the News for 908 Devices 908 Devices updated full year 2026 earnings guidance, setting a revenue range of $68.0 million to $70.0 million and lifting the lower end from $67.0 million.
MASS: Raised 2026 Outlook And Index Removals Will Shape Future P/E
Analysts have raised their fair value estimate for 908 Devices from $10 to $12, citing updates to key assumptions, including the discount rate, revenue growth outlook, profit margin profile, and future P/E expectations. What’s in the News for 908 Devices 908 Devices updated its full year 2026 revenue guidance to a range of $68.0 million to $70.0 million, compared with the previous range of $67.0 million to $70.0 million.908 Devices: Mission Critical Devices Drive Growth
Summary 908 Devices is rated BUY after a 2Q26 earnings beat, strong revenue growth, and a 97% YTD share price gain. MASS benefits from robust demand for chemical detection devices, driven by law enforcement, defense, and volatile geopolitical conditions. Recurring revenue from NIRLab and product upgrades like VipIR underpin stable growth; management raised FY26 revenue guidance to $68–$70M. Valuation remains reasonable at 5.5x forward P/S, supported by a $101.5M cash position, no debt, and narrowing EBITDA losses. Read the full article on Seeking Alpha
MASS: Index Removals Will Set Up A Future Repricing Opportunity
Analysts have updated their fair value estimate for 908 Devices from $12.00 to $14.00, reflecting revised assumptions around revenue growth, profit margins, discount rates, and future P/E expectations. What’s in the News for 908 Devices 908 Devices was dropped from the Russell 2500 Growth Benchmark, according to index classification data.Recent updates
MASS: Higher 2026 Revenue Outlook Will Support A Stronger Share Price
Analysts have raised the 908 Devices fair value estimate from $11 to $13, citing updated assumptions on the discount rate, revenue growth, profit margin, and future P/E that shift their overall price target framework. What’s in the News for 908 Devices 908 Devices updated full year 2026 earnings guidance, setting a revenue range of $68.0 million to $70.0 million and lifting the lower end from $67.0 million.MASS: Raised 2026 Outlook And Index Removals Will Shape Future P/E
Analysts have raised their fair value estimate for 908 Devices from $10 to $12, citing updates to key assumptions, including the discount rate, revenue growth outlook, profit margin profile, and future P/E expectations. What’s in the News for 908 Devices 908 Devices updated its full year 2026 revenue guidance to a range of $68.0 million to $70.0 million, compared with the previous range of $67.0 million to $70.0 million.908 Devices: Mission Critical Devices Drive Growth
Summary 908 Devices is rated BUY after a 2Q26 earnings beat, strong revenue growth, and a 97% YTD share price gain. MASS benefits from robust demand for chemical detection devices, driven by law enforcement, defense, and volatile geopolitical conditions. Recurring revenue from NIRLab and product upgrades like VipIR underpin stable growth; management raised FY26 revenue guidance to $68–$70M. Valuation remains reasonable at 5.5x forward P/S, supported by a $101.5M cash position, no debt, and narrowing EBITDA losses. Read the full article on Seeking AlphaMASS: Index Removals Will Set Up A Future Repricing Opportunity
Analysts have updated their fair value estimate for 908 Devices from $12.00 to $14.00, reflecting revised assumptions around revenue growth, profit margins, discount rates, and future P/E expectations. What’s in the News for 908 Devices 908 Devices was dropped from the Russell 2500 Growth Benchmark, according to index classification data.MASS: Raised 2026 Revenue Outlook Will Support A Higher Stock Price
Analysts have lifted their price target on 908 Devices stock from $10.00 to $11.00, citing updated assumptions around fair value, revenue growth, discount rate and future P/E that they consider better aligned with the company's current outlook. What’s in the News for 908 Devices 908 Devices raised its full year 2026 revenue guidance, according to a key developments summary.MASS: Raised 2026 Revenue Outlook Will Support Higher Future P/E Multiple
Analysts have modestly adjusted their price targets on 908 Devices, reflecting updated assumptions for a fair value of $10.00, a slightly higher discount rate, marginally stronger projected revenue growth, a softer profit margin outlook, and a higher future P/E of about 70x. What's in the News 908 Devices raised its full year 2026 revenue guidance to a range of $67.0 million to $70.0 million.MASS: Raised 2026 Revenue Guidance Will Support Higher Earnings Multiple
Analysts have reset their price target on 908 Devices to $10.00 from $8.00, citing updated assumptions around revenue growth, profitability, and future P/E that feed into a higher fair value estimate and a modestly higher discount rate. What's in the News 908 Devices raised full year 2026 revenue guidance to a range of $67.0 million to $70.0 million, compared with 2025 revenue, with the range described as representing 19% to 25% growth (Corporate Guidance: Raised).908 Devices Inc.'s (NASDAQ:MASS) 29% Price Boost Is Out Of Tune With Revenues
Those holding 908 Devices Inc. ( NASDAQ:MASS ) shares would be relieved that the share price has rebounded 29% in the...Some 908 Devices Inc. (NASDAQ:MASS) Shareholders Look For Exit As Shares Take 26% Pounding
908 Devices Inc. ( NASDAQ:MASS ) shareholders won't be pleased to see that the share price has had a very rough month...908 Devices Inc.'s (NASDAQ:MASS) Share Price Not Quite Adding Up
When close to half the companies in the Electronic industry in the United States have price-to-sales ratios (or "P/S...908 Devices Inc. (NASDAQ:MASS) Analysts Are Pretty Bullish On The Stock After Recent Results
NasdaqGM:MASS 1 Year Share Price vs Fair Value Explore 908 Devices's Fair Values from the Community and select yours...US Federal And International Funding Will Expand Global Analysis Markets
The notable increase in 908 Devices’ price target reflects improved outlook due to higher expected revenue growth and an expanded forward P/E, raising the consensus fair value from $6.50 to $9.00. What's in the News 908 Devices raised its 2025 revenue guidance to $54–56 million (13–17% growth), up from prior guidance of $53–55 million.908 Devices Inc.'s (NASDAQ:MASS) Shares Climb 26% But Its Business Is Yet to Catch Up
Despite an already strong run, 908 Devices Inc. ( NASDAQ:MASS ) shares have been powering on, with a gain of 26% in the...
The New Handheld Mass Spectrometer Launch Will Expand Market Reach
Divesting the desktop bioprocessing portfolio boosts cash reserves, streamlines operations, and is expected to enhance margins and cash flow in future years.908 Devices Makes Key Divestiture (Rating Upgrade)
Summary 908 Devices' stock surged after announcing a $70 million desktop portfolio sale, doubling its cash position and improving financial stability. The company will now focus on its handheld device business, expecting 11% to 15% revenue growth in 2025 with acceleration in 2026. MASS management believes losses will be significantly reduced with the new structure, with positive cash flow next year. Read the full article on Seeking Alpha908 Devices Inc.'s (NASDAQ:MASS) 55% Jump Shows Its Popularity With Investors
The 908 Devices Inc. ( NASDAQ:MASS ) share price has done very well over the last month, posting an excellent gain of...Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts
The analysts might have been a bit too bullish on 908 Devices Inc. ( NASDAQ:MASS ), given that the company fell short...908 Devices: Key Investor Now Selling
Summary ARK Invest's recent sales of 908 Devices shares have helped to send the stock to multi-year lows. 908 Devices is seeing decent revenue growth, but large losses and limited financial flexibility raise concerns about future capital needs. The stock's low valuation compared to peers is a positive, but ongoing sales by ARK Invest could exert further downward pressure. Read the full article on Seeking AlphaWhy We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge
To the annoyance of some shareholders, 908 Devices Inc. ( NASDAQ:MASS ) shares are down a considerable 29% in the last...We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Investors Appear Satisfied With 908 Devices Inc.'s (NASDAQ:MASS) Prospects
When you see that almost half of the companies in the Electronic industry in the United States have price-to-sales...Rendement pour les actionnaires
| MASS | US Electronic | US Marché | |
|---|---|---|---|
| 7D | -6.2% | 4.9% | -0.2% |
| 1Y | 70.0% | 47.7% | 14.8% |
Rendement vs Industrie: MASS a dépassé le secteur US Electronic qui a rapporté 47.7 % au cours de l'année écoulée.
Rendement vs marché: MASS a dépassé le marché US qui a rapporté 14.8 % au cours de l'année écoulée.
Volatilité des prix
| MASS volatility | |
|---|---|
| MASS Average Weekly Movement | 7.6% |
| Electronic Industry Average Movement | 9.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Cours de l'action stable: MASS n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.
Volatilité au fil du temps: La volatilité hebdomadaire de MASS ( 8% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 2012 | 172 | Kevin Knopp | 908devices.com |
908 Devices Inc. propose des appareils portatifs de spectrométrie de masse et d'infrarouge à transformée de Fourier (FTIR) destinés à des applications vitales dans le domaine de la santé et de la sécurité. Les produits de la société comprennent le MX908, un appareil de spectrométrie de masse portatif alimenté par batterie et conçu pour l'analyse rapide de matériaux solides, liquides, de vapeur et d'aérosols dont l'identité est inconnue ; le XplorIR, un appareil portatif qui utilise la spectroscopie FTIR pour identifier, quantifier et suivre les gaz et les vapeurs ; ThreatID, un appareil FTIR portable qui détecte et identifie rapidement environ 28 000 gaz, vapeurs, poudres et liquides inconnus ; ProtectIR, un appareil FTIR portable qui peut identifier environ 23 000 dangers chimiques solides et liquides ; et VipIR, un analyseur 3-en-1 portable qui intègre la spectroscopie FTIR, la spectroscopie Raman et le traitement spectral intelligent (SSP), un algorithme propriétaire, pour fournir un résultat unique à partir d'un seul échantillon. Elle opère aux États-Unis, en Europe, au Moyen-Orient, en Afrique, en Asie-Pacifique et dans le reste des Amériques.
908 Devices Inc. Résumé des fondamentaux
| MASS statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$405.48m |
| Bénéfices(TTM) | -US$34.38m |
| Recettes(TTM) | US$60.84m |
Le site MASS est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| MASS compte de résultat (TTM) | |
|---|---|
| Recettes | US$60.84m |
| Coût des recettes | US$28.81m |
| Marge brute | US$32.03m |
| Autres dépenses | US$66.41m |
| Les revenus | -US$34.38m |
Derniers bénéfices déclarés
Jun 30, 2026
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | -0.83 |
| Marge brute | 52.65% |
| Marge bénéficiaire nette | -56.51% |
| Ratio dettes/capitaux propres | 0% |
Quelles ont été les performances à long terme de MASS?
Voir les performances historiques et les comparaisonsAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/09/09 22:31 |
| Cours de l'action en fin de journée | 2026/09/09 00:00 |
| Les revenus | 2026/06/30 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
908 Devices Inc. est couverte par 5 analystes. 5 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Puneet Souda | Leerink Partners LLC |
| Max Masucci | Roth Capital Partners |
| Daniel Arias | Stifel, Equities Research |